T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Tesla
TSLA
|
+$5.14B |
| 2 |
JPMorgan Chase
JPM
|
+$2.05B |
| 3 |
Atlassian
TEAM
|
+$2.04B |
| 4 |
NVIDIA
NVDA
|
+$1.97B |
| 5 |
Apple
AAPL
|
+$1.73B |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.32B |
| 2 |
Microsoft
MSFT
|
+$2.74B |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.74B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.9B |
| 5 |
Hilton Worldwide
HLT
|
+$1.79B |
Sector Composition
| 1 | Technology | 26.88% |
| 2 | Healthcare | 17.2% |
| 3 | Consumer Discretionary | 15.14% |
| 4 | Financials | 10.69% |
| 5 | Communication Services | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
Monte Rosa Therapeutics
GLUE
$299M
| $75M | 0.01% |
5,350,923
+1,204,004
| +29% | +$16.9M |
|
827
Choice Hotels
CHH
$5.29B
| $74.7M | 0.01% |
526,925
+34,117
| +7% | +$4.84M |
|
828
United Parks & Resorts
PRKS
$2.81B
| $74.2M | 0.01% |
996,425
-90,891
| -8% | -$6.77M |
|
829
Scholar Rock
SRRK
$3.04B
| $73.9M | 0.01% |
5,731,743
+469,142
| +9% | +$6.05M |
|
|
CFB
830
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $73.4M | 0.01% |
4,657,247
-25,681
| -0.5% | -$405K |
|
831
CRISPR Therapeutics
CRSP
$5.04B
| $73.2M | 0.01% |
1,166,114
+75,301
| +7% | +$4.73M |
|
832
Archer Daniels Midland
ADM
$29.6B
| $73M | 0.01% |
809,225
-39,105
| -5% | -$3.53M |
|
833
Tandem Diabetes Care
TNDM
$866M
| $73M | 0.01% |
627,697
+3,886
| +0.6% | +$452K |
|
834
Targa Resources
TRGP
$35.5B
| $73M | 0.01% |
966,755
-405,924
| -30% | -$30.6M |
|
|
TXNM
835
TXNM Energy, Inc.
TXNM
$6B
| $72.9M | 0.01% |
1,530,006
+939,067
| +159% | +$44.8M |
|
836
EXL Service
EXLS
$7.07B
| $72.7M | 0.01% |
2,536,510
-51,700
| -2% | -$1.48M |
|
837
Autodesk
ADSK
$69.2B
| $72.3M | 0.01% |
337,222
-20,463
| -6% | -$4.39M |
|
838
Maravai LifeSciences
MRVI
$395M
| $72.3M | 0.01% |
2,048,957
+102,221
| +5% | +$3.61M |
|
839
SPS Commerce
SPSC
$4.28B
| $72M | 0.01% |
548,831
-75,246
| -12% | -$9.87M |
|
840
Gentherm
THRM
$1.1B
| $71.8M | 0.01% |
982,766
-164,816
| -14% | -$12M |
|
841
Huron Consulting
HURN
$2.43B
| $71.5M | 0.01% |
1,560,664
+32,423
| +2% | +$1.49M |
|
|
SAGE
842
DELISTED
Sage Therapeutics
SAGE
| $71.4M | 0.01% |
2,158,504
+741,982
| +52% | +$24.6M |
|
843
Red Rock Resorts
RRR
$3.67B
| $71.1M | 0.01% |
1,464,403
+342,544
| +31% | +$16.6M |
|
844
Watsco
WSO
$16.2B
| $70.9M | 0.01% |
232,810
-1,872
| -0.8% | -$570K |
|
845
Boston Omaha
BOC
$426M
| $70.6M | 0.01% |
2,781,339
-291
| -0% | -$7.38K |
|
|
PMT
846
PennyMac Mortgage Investment
PMT
$1.09B
| $70.1M | 0.01% |
4,149,083
-27,230
| -0.7% | -$460K |
|
847
Boyd Gaming
BYD
$6.92B
| $70M | 0.01% |
1,063,574
-95,804
| -8% | -$6.3M |
|
|
AZPN
848
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $69.9M | 0.01% |
422,478
-56,498
| -12% | -$9.34M |
|
849
Nexstar Media Group
NXST
$6.15B
| $69.5M | 0.01% |
368,641
+20,182
| +6% | +$3.8M |
|
850
Asana
ASAN
$3.19B
| $69.4M | 0.01% |
1,736,919
+1,701,649
| +4,825% | +$68M |
|